| scholarly article | Q13442814 |
| P50 | author | Sebastien Ourselin | Q88381761 |
| Magdalena Sokolska | Q89181808 | ||
| Kwee L Yong | Q90710845 | ||
| Shirley D'Sa | Q110168886 | ||
| Stuart A Taylor | Q55482817 | ||
| Nikolaos Dikaios | Q56854785 | ||
| Michela Antonelli | Q57943577 | ||
| Steve Halligan | Q57943824 | ||
| P2093 | author name string | Alan Bainbridge | |
| Shonit Punwani | |||
| Neil Rabin | |||
| Rakesh Popat | |||
| Margaret Hall-Craggs | |||
| Ali Rismani | |||
| Arash Latifoltojar | |||
| P2860 | cites work | Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy | Q79676715 |
| Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results | Q84178655 | ||
| MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings | Q26750794 | ||
| Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): application with fast spin-echo imaging. | Q30999063 | ||
| Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) imaging of multiple myeloma: initial clinical efficiency results | Q34090190 | ||
| International uniform response criteria for multiple myeloma. | Q34549410 | ||
| Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation | Q35606328 | ||
| Multiple myeloma: clinical review and diagnostic imaging | Q35678276 | ||
| Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma | Q36366654 | ||
| Whole body diffusion weighted MRI--a new view of myeloma | Q36532924 | ||
| Assessing response of myeloma bone disease with diffusion-weighted MRI. | Q36727138 | ||
| Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives | Q37232368 | ||
| Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging | Q37679475 | ||
| Biomarkers in imaging: realizing radiology's future | Q40597532 | ||
| Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study | Q40691084 | ||
| Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement | Q41552459 | ||
| Whole-Body MRI versus PET in assessment of multiple myeloma disease activity | Q46079313 | ||
| Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? | Q46579579 | ||
| Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma | Q46640882 | ||
| Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma. | Q48881734 | ||
| Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma | Q49124195 | ||
| Three-point Dixon method enables whole-body water and fat imaging of obese subjects. | Q51612452 | ||
| Multiple myeloma: MR patterns of response to treatment. | Q52871181 | ||
| Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. | Q53427970 | ||
| Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma | Q56770350 | ||
| Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging | Q56781760 | ||
| Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma | Q64025788 | ||
| Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers | Q74587986 | ||
| Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma | Q74624015 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| whole-body MRI | Q110972658 | ||
| P304 | page(s) | 5325-5336 | |
| P577 | publication date | 2017-06-27 | |
| P1433 | published in | European Radiology | Q5413071 |
| P1476 | title | Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction | |
| P478 | volume | 27 |
| Q89919144 | Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI |
| Q47875690 | Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology. |
| Q47697058 | Functional and molecular MRI of the bone marrow in multiple myeloma |
| Q92614906 | How rapid advances in imaging are defining the future of precision radiation oncology |
| Q88955829 | Proton density fat fraction (PDFF) MR imaging for differentiation of acute benign and neoplastic compression fractures of the spine |
| Q50128047 | Proton density fat fraction (PDFF) MRI for differentiation of benign and malignant vertebral lesions |
| Q89450442 | Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response |
| Q47404572 | UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer. |
| Q47732077 | WB MRI and oncology: recent major advances. |
| Q57943363 | Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin’s lymphoma: a comparison with multi-modality reference standard including 18F-FDG-PET-CT |
| Q58564104 | Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences |
| Q60714624 | Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses |
| Q92095077 | Whole-body magnetic resonance imaging in paediatric Hodgkin lymphoma - evaluation of quantitative magnetic resonance metrics for nodal staging |
Search more.